Tokyo, Japan

Honda Kazuo

This inventor holds 1 USPTO granted patent. Top assignee: Tms Company LLC. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Honda Kazuo. Retrieved from https://idiyas.com/inventor/honda-kazuo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Honda Kazuo

Introduction

Honda Kazuo is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of cytoprotection, particularly in relation to ischemic damage. His innovative work has led to the development of a unique cytoprotective agent.

Latest Patents

Honda Kazuo holds one patent for a cytoprotective agent. This agent includes a triprenyl phenol compound represented by a specific general formula. The formula outlines the structural components necessary for its function, emphasizing its potential in medical applications.

Career Highlights

Throughout his career, Honda Kazuo has focused on advancing medical science through his inventions. His work has been recognized for its potential impact on treating ischemic conditions, showcasing his dedication to improving health outcomes.

Collaborations

Honda has collaborated with notable colleagues, including Terumasa Hashimoto and Keita Shibata. These partnerships have likely contributed to the innovative nature of his work and the successful development of his patent.

Conclusion

Honda Kazuo's contributions to the field of cytoprotection highlight his role as an influential inventor. His patent reflects a commitment to advancing medical science and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…